Vimarsana
Biggest News Aggregation in the World

Page 8 - Tim Dyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim Dyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Dyer Today - Breaking & Trending Today

Addex Therapeutics: Addex Completes $5.0 Million Equity Financing - Vimarsana News

Addex Therapeutics: Addex Completes $5.0 Million Equity Financing

Proceeds to advance allosteric modulator therapeutic pipeline Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 5, 2023 - Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN)

Addex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson's Disease - Vimarsana News

Addex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson's Disease

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 4, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug... | April 4, 2023

Cogent Global Solutions, Inc. Announces the Global Launch of New NxLCP Medical Presentation System f - Vimarsana News

Cogent Global Solutions, Inc. Announces the Global Launch of New NxLCP Medical Presentation System f

DENVER--(BUSINESS WIRE)--Cogent Global Solutions today announces the launch of a new Next Level Clinical Presentations (NxLCP) system. The system is designed specifically to address the needs of surgeons communicating new technology revolutionizing modern medicine.Proprietary to Cogent, the NxLCP system accommodates...

Addex Therapeutics: Addex Provides Corporate Update and Financial Guidance - Vimarsana News

Addex Therapeutics: Addex Provides Corporate Update and Financial Guidance

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, January 19, 2023 - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based

Addex and Indivior Extend Research Term of Substance Use Disorder GABAB Positive Allosteric Modulator Discovery Collaboration - Vimarsana News

Addex and Indivior Extend Research Term of Substance Use Disorder GABAB Positive Allosteric Modulator Discovery Collaboration

08.12.2022 - Addex to receive USD 1 million in additional research fundingCollaboration continues to advance through drug candidate selection phase Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, December 8, 2022 - Addex Therapeutics (SIX and ... Seite 1